In other malignancies such as breast cancer, it has been shown that liprin has several cancer-promoting functions when found in tumor cells [12, 23, 28], for example, the ability to increase cell motility and extracellular matrix degradation, and thus, invasiveness. Here, PPFIA1 is linked to breast carcinoma.